CLC bio part of $7.8M EU STATegra grant to develop integral analysis platform for epigenetics
05:39 EST 12 Dec 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Today CLC bio announced the participation in the European FP7 project,
STATegra, and receives 1.3 million US Dollars out of the total $7.8M
project budget. STATegra aims to develop a user-friendly integral
analysis platform for ...
Other Sources for this Article
CLC bio
Lasse Görlitz, VP of Communications
Phone: +1
(617) 765-0687
E-mail: lgoerlitz@clcbio.com
More From BioPortfolio on "CLC bio part of $7.8M EU STATegra grant to develop integral analysis platform for epigenetics"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
